advertisement

Topcon

Abstract #90104 Published in IGR 21-3

Management of Anticoagulation and Antiplatelet Therapy in Glaucoma Surgery

Shukla AG; Shukla AG; Ramulu PY
Journal of Glaucoma 2020; 29: 732-741


The use of antithrombotic therapy is rising as the population of older adults grows and novel agents with wider indications emerge. Likewise, surgical treatment of glaucoma may become increasingly common as the prevalence of glaucoma increases and innovative treatment options are developed. These trends highlight the need to understand how best to manage antithrombotic therapy in the context of glaucoma surgery. This review article describes current literature on antithrombotic therapy and perioperative thromboembolic risk evaluation based on individual factors. In addition, guidance is offered on the management of antithrombotic therapy in the setting of each type of glaucoma surgery, with an emphasis on a multidisciplinary approach involving the patients' treating physicians.

Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA.

Full article

Classification:

12.20 Other (Part of: 12 Surgical treatment)
11.15 Other drugs in relation to glaucoma (Part of: 11 Medical treatment)



Issue 21-3

Change Issue


advertisement

Oculus